As of 4:02pm ET
| -0.30 / -0.79%|
The 18 analysts offering 12-month price forecasts for Imperva Inc have a median target of 45.00, with a high estimate of 57.00 and a low estimate of 30.00. The median estimate represents a +19.05% increase from the last price of 37.80.
The current consensus among 21 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.